Through the analysis of clinical samples from ovarian and breast cancer patients, Sun P et al. (Sun D. et al., 2021), discovered a downregulation of miR-382-5p expression, while observing an upregulation of SLC7A11 expression. This evidence concerns the gene SLC7A11 and breast cancer.